![Wolfgang Berthold](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wolfgang Berthold is currently the President of Berthold BioPharm Consulting GmbH since 2011.
Prior to this, he worked as a Principal at IDEC Corp., Boehringer Ingelheim BV, and Roche Corp.
He also served as a Member-Supervisory Board at Merus NV and as the CTO & Senior VP-Technology Development at Biogen International GmbH.
Dr. Berthold holds a doctorate degree from the University of London.
| Società | Posizione | Inizio |
|---|---|---|
Berthold BioPharm Consulting GmbH | Presidente | 01/01/2011 |
| Società | Posizione | Fine |
|---|---|---|
Biogen International GmbH
 Biogen International GmbH Pharmaceuticals: MajorHealth Technology Produces pharmaceuticals | Direttore Tecnico/Scientifico/R&S | - |
Roche Corp. | Corporate Officer/Principal | - |
| MERUS N.V. | Direttore/Membro del Consiglio | - |
Boehringer Ingelheim BV
 Boehringer Ingelheim BV Drugstore ChainsRetail Trade Develops and markets drugs | Corporate Officer/Principal | - |
| IDEC CORPORATION | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
| Aziende private | 7 |
|---|---|
IDEC Corp.
 IDEC Corp. Electronic Equipment/InstrumentsElectronic Technology Manufactures and distributes control equipment & related products | Electronic Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Boehringer Ingelheim BV
Boehringer Ingelheim BV Drugstore ChainsRetail Trade Develops and markets drugs | Retail Trade |
Roche Corp. | |
Biogen International GmbH
Biogen International GmbH Pharmaceuticals: MajorHealth Technology Produces pharmaceuticals | Health Technology |
Berthold BioPharm Consulting GmbH |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
